CAMELOT Consulting Group Turns 25
Find the top achievements and successful milestones of our 25-year company history summarized here.
Due to the COVID-19 pandemic, life science companies are facing unprecedented commercialization model disruptions. This has forced them to rapidly shift their digital initiatives from planning to execution, highlighting the need for agility over completeness. We believe this Gartner Hype Cycle report offers an objective review of key technologies and trends that support and drive commercial effectiveness and, we believe, reveals which ones are a must-have for your organization’s transformation.
The importance of data and analytics will continue to grow. And with it, the role it will play in the evolution of clinical care and operations in the future. However, there are further challenges for life science leaders: pressure, dynamic and uncertain regulatory hurdles, cultural barriers to change as well as new digital competitors.
To “go beyond the pill” and embrace patient centricity, we believe, you must align your IT enterprise approach and plans for emerging technologies with your company’s chosen role in an overall digital healthcare ecosystem. This Hype Cycle tracks key technologies and trends that support and drive commercial effectiveness.
There are many emerging technologies to be applied in life science commercial operations. The following selection, based on Gartner’s research and our own expertise as a technology and industry specialist, shows what life science leaders need to look out for in the time ahead.
Selected transformational life science technologies in the next 10 years:
Explore how biotech companies can improve efficiency, sustainability and resilience through designing an innovative value chain model.
Read more about 10 capabilities biotech companies need to exploit the full potential of their value chains.
Download the success story of our client and learn how to transform data into value.
Camelot’s recognized expertise in building technology-enabled highly reliable, flexible, and patient-centric value chains is the reason why life science clients have been turning to us for more than 25 years. With our spin-off Hypertrust Patient Data Care, we provide dedicated digital solutions which make the supply chain of Advanced & Personalized Therapies run.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and is used herein with permission. All rights reserved.
Our experts will contact you soon to arrange a call or meeting.